**The year 2003**

1**Use of HRT in a million women (Aug 9, 2003)**Beral V and Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. [DOI:10.1016/S0140-6736(03)14065-2](10.1016/S0140-6736(03)14065-2). *Lancet* 2003; **362:** 419--27.2**Protecting the heart (July 6, 2002)**Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. [DOI:10.1016/S0140-6736(02)09327-3](10.1016/S0140-6736(02)09327-3). *Lancet* 2002; **360:** 7--22.3**ASCOT: the benefits of lipid lowering (April 5, 2003)**Sever PS, Dahlöf B, Poulter NR for the ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial----Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. [DOI:10.1016/S0140-6736(03)12948-0](10.1016/S0140-6736(03)12948-0). *Lancet* 2003; **361:** 1149--58.4**Coronavirus implicated in SARS (April 19, 2003)**Peiris JSM, Lai ST, PoonLLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. [DOI:10.1016/S0140-6736(03)13077-2](10.1016/S0140-6736(03)13077-2). *Lancet* 2003; **361:** 1319--25.5**COMET (July 5, 2003)**Poole-Wilson PA, Swedberg K, Cleland JGF, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. [DOI:10.1016/S0140-6736(03)13800-7](10.1016/S0140-6736(03)13800-7). *Lancet* 2003; **362:** 7--13.6**Advances in cystic fibrosis (Feb 22, 2003)**Ratjen F, Döring G. Cystic fibrosis. [DOI:10.1016/S0140-6736(03)12567-6](10.1016/S0140-6736(03)12567-6). *Lancet* 2003; **361:** 681--89.7**Elusive schizophrenia genes (Feb 1, 2003)**Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. [DOI:10.1016/S0140-6736(03)12379-3](10.1016/S0140-6736(03)12379-3). *Lancet* 2003; **361:** 417--19.8**Detecting ovarian cancer (Feb 16, 2002)**Petricoin III EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. [DOI:10.1016/S0140-6736(02)07746-2](10.1016/S0140-6736(02)07746-2). *Lancet* 2002; **359:** 572--77.9**Statins advocated in diabetes (June 14, 2003)**Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. [DOI:10.1016/S0140-6736(03)13636-7](10.1016/S0140-6736(03)13636-7). *Lancet* 2003; **361:** 2005--16.10**COOPERATion (Jan 11, 2003)**Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. [DOI:10.1016/S0140-6736(03)12229-5](10.1016/S0140-6736(03)12229-5). *Lancet* 2003; **361:** 117--24.
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